Ide Takeshi Department
Hyogo Medical University(Corporation/Other Facilities)
Intensive Care Unit, Central Clinic
Position
■ Journal
1.
Original article
Passive exercise of the lower limbs and trunk alleviates decreased intestinal motility in patients in the intensive care unit sfter cardiovascular surgery. 2017/02
2.
Original article
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy:dosage considerations 2017/03
3.
Original article
Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy. 2018/02
■ Presentation
1.
Pharmacokinetics of daptomycin (dap) in patients undergoing low-flow continuous veno-venous hemodiafiltration (cvvhdf) (Poster presentation,General Lecture) 2015/03/17
2.
Effects of lower limbs and trunk passive exercise on intestinal movement after cardiovascular surgery (Poster presentation,General Lecture) 2015/05/01
3.
Effect of recombinant human soluble thrombomodulin on septic disseminated intravascular coagulation. (Poster presentation,General Lecture) 2015/08/31
4.
Dosage Modification of Linezolid in Patients Undergoing Continuous Venovenous Hemodiafiltration. (Poster presentation,General Lecture) 2016/06/16
5.
Pharmacokinetics of Daptomycin (Dap) in Patients Undergoing Continuous Veno-Venous Hemodiafiltration (Cvvhdf). (Poster presentation,General Lecture) 2016/06/16
6.
Pharmacokinetics of Daptomycin (DAP) in Patients Undergoing Continuous Veno-Venous Hemodiafiltration (CVVHDF) (Poster presentation,General Lecture) 2016/06/18
7.
COMBINATION THERAPY WITH RECOMBINANT THROMBOMODULIN AND POLYMYXIN-B DIRECT
HYEMOPERFUSION IN 4 PATIENTS WITH SEPTIC SHOCK AND DISSEMINATED INTRAVASCULAR
COAGULATION (Poster presentation,General Lecture) 2016/08/28
8.
PHARMACOKINETICS OF PIPERACILLIN-TAZOBACTAM IN PATIENTS UNDERGOING CONTINUOUS RENAL REPLACEMENT THERAPY (Poster presentation,General Lecture) 2016/10/14
9.
Treatment effect of recombinant human soluble thrombomodulin(rTM)alone and anti-thrombin III(AT) alone on septic disseminated intravascular coagulation(DIC) (Poster presentation,General Lecture) 2017/10
10.
PHARMCOKINETICS OF TAZOBACTAM/PIPERACILLIN IN PATIENTS UNDERGOING CONTINUOUS RENAL REPLACEMENT THERAPY (Poster presentation,General Lecture) 2018/10/11